Sort by
Keyphrases
Ovulation
100%
RU486
100%
Bleeding Pattern
100%
Late Luteal Phase
100%
Placebo
27%
Consecutive Days
18%
Menses
18%
Luteal Phase
18%
Menstrual Bleeding
18%
Follicular Phase
9%
Progesterone
9%
High Affinity
9%
FSH Level
9%
LH Level
9%
Vaginal Progesterone
9%
Bleeding
9%
Menstrual Cycle
9%
High-risk Pregnancy
9%
Consecutive Cycles
9%
Serum LH
9%
Serum Estradiol Level
9%
First Cycle
9%
Drug Administration
9%
Hormonal Parameters
9%
Corpus Luteum Function
9%
Natural Progesterone
9%
Non-pregnant Women
9%
Pregnanediol Glucuronide
9%
Early Morning
9%
Luteinization
9%
Estrone Glucuronide
9%
Progesterone Withdrawal
9%
Urinary LH
9%
Agricultural and Biological Sciences
Progesterone
100%
Ovulation
100%
Placebo
100%
Estradiol
33%
Glucocorticoid
33%
Urinary System
33%
Menstrual Cycle
33%
Corpus Luteum
33%
Estrone
33%
Pregnanediol
33%
Luteinization
33%
Neuroscience
Placebo
100%
Progesterone
100%
Glucocorticoid
33%
Diethylstilbestrol
33%
Corpus Luteum
33%
Glucuronide
33%
Pregnanediol
33%
Estrone Glucuronide
33%
Estrone
33%
Nursing and Health Professions
Mifepristone
100%
Bleeding
45%
Placebo
27%
Progesterone
27%
Diethylstilbestrol
9%
Glucocorticoid
9%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
9%
Pregnanediol
9%
Estrone Glucuronide
9%
Drug Administration
9%
Estrone
9%
Glucuronide
9%
Target Tissue
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mifepristone
100%
Bleeding
45%
Progesterone
27%
Placebo
27%
Diethylstilbestrol
9%
Glucocorticoid
9%
Drug Administration
9%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
9%
Pregnanediol
9%
Estrone Glucuronide
9%
Glucuronide
9%
Estrone
9%